Top Markets
Coin of the day
LAUNXP Biomedical Co., Ltd LAUNXP Biomedical Co., Ltd

LAUNXP Biomedical Co., Ltd

6876
Rangering i aksjer #28267
LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical... LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical treatments for various types of cancer. Their product line includes therapies designed to combat tumor growth and inhibit cell proliferation, notably utilizing advanced platforms such as virus-like nanoparticles and other nanoparticle-based drug delivery systems. The company was established on September 24, 2015, and its primary corporate operations are based in Taichung, Taiwan.
Aksjekurs
$0.3958979
Markedsverdi
$27.40M
Endring (1 dag)
-0.40%
Endring (1 år)
-48.96%
Land
TW
Handel LAUNXP Biomedical Co., Ltd (6876)

Kategori

EPS for LAUNXP Biomedical Co., Ltd (6876)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til LAUNXP Biomedical Co., Ltd er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for LAUNXP Biomedical Co., Ltd fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -
US
$-7.98 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH